Can-Fite BioPharma Ltd. - Ordinary Shares, no par value (CANF)

CUSIP: 13471N300

Q2 2025 13F Holders as of 30 Jun 2025

Security type / class
Equity / Ordinary Shares, no par value
Total 13F shares
904,884
Total 13F value
$950,122
Holder snapshot 6 signals
Share change
+778,653
SEC-reported price per share
$1.05
Number of holders
15
Value change
+$805,185
Number of buys
7
Number of sells
4
Security identity 1 source field
Shares outstanding
3,838,602,439

Security key

13471N300

Report period

Q2 2025

Institutions

15

Top holders

10

CANF full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 Previous quarter: Q1 2025 Can-Fite BioPharma Ltd. SEC filings Can-Fite BioPharma Ltd. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of CANF - Can-Fite BioPharma Ltd. - Ordinary Shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
Orca Capital AG
Comparable rows
15/15
Latest evidence
22 Apr 2025
13D/G 13F Lead comparable stake: 5% 13D/G row: ARMISTICE CAPITAL, LLC Showing 1-6 of 15 holder rows.

Quick read

ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 5%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Comparable ownership Top 5
ARMISTICE CAPITAL, LLC 5%
Orca Capital AG 4.1%
RHUMBLINE ADVISERS 0%
MORGAN STANLEY 0%
BNP PARIBAS FINANCIAL MARKETS 0%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ARMISTICE CAPITAL, LLC
13D/G
13D/G
5%
$528,506
440,422 shares
 $0 31 Dec 2024
Orca Capital AG
13D/G
13D/G
4.1%
$188,859,240
157,382,700 shares
 -$261,140,760 22 Apr 2025
RHUMBLINE ADVISERS
13F
Company
13F
0%
$56,630
38,268 shares
 — 31 Mar 2025
MORGAN STANLEY
13F
Company
13F
0%
$34,354
23,212 shares
 — 31 Mar 2025
BNP PARIBAS FINANCIAL MARKETS
13F
Company
13F
0%
$33,426
22,585 shares
 — 31 Mar 2025
XTX Topco Ltd
13F
Company
13F
0%
$22,601
15,271 shares
 — 31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
15
Shares
904,884
Rows available
15
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
13
Q2 2025 holders
15
Holder diff
2
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 value Q2 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .